Nawi, Sania M.

HRN: 04-21-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2025
04/23/2025
IV
4.5g
Q8h
CAP HR
Waiting Final Action 
04/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2025
04/23/2025
IV
4.5g
Q6h
PNEUMONIA
Waiting Final Action 
04/17/2025
LEVOFLOXACIN 500MG (TAB)
04/17/2025
04/24/2025
PO
500
OD
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: